Novartis | Renteudgifter På Gæld



Interest Expense On Debt Lave om Dato
AbbVie USD 610M 19M 2024-12
Alcon AG USD 48M 1000K 2024-12
Amgen USD 723M 24M 2025-03
AstraZeneca 429M 28M 2024-12
Bayer 703M 61M 2024-12
Biogen USD 60M 200K 2024-12
Bristol-Myers Squibb USD 494M 2M 2025-03
Eli Lilly USD 243.7M 19M 2025-03
Fresenius 116M 105.2M 2024-09
Fresenius Medical Care EUR 101M 2M 2024-12
Galapagos EUR 50.12M 49.87M 2024-09
Genmab DKK 2.68B 1.98B 2024-12
Gilead Sciences USD 260M 12M 2025-03
GlaxoSmithKline 162M 11M 2025-03
GRIFOLS EUR 202.71M 94.07M 2024-06
Hikma Pharmaceutical 22M 9M 2024-06
J&J USD 128M 9M 2025-03
Lonza CHF 59M 6M 2024-06
Merck 76M 13M 2024-12
Merck USD 313M 15M 2025-03
Novartis USD 275M 11M 2024-12
Novartis USD 275M 11M 2024-12
Novo Nordisk 562M 40M 2024-09
Orion 1000K 100K 2025-03
Pfizer USD 654M 85M 2025-03
Philips 104M 95.2M 2024-09
Recordati EUR 29.38M 13.85M 2024-12
Regeneron Pharmaceuticals USD 8.7M 1.8M 2025-03
Roche Holding CHF 311.5M 1000K 2024-12
Sanofi 213M 151M 2025-03



Novartis Renteudgifter På Gæld - Aktuelle værdier, historiske data, prognoser, statistik, diagrammer og økonomisk kalender - May 2025.